Across TCGA pan-cancer cohorts, CDK5RAP3 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated CDK5RAP3 data layer compared with 24 for mass-spec protein and 5 for mutation status.
The strongest signal is observed in colon adenocarcinoma (COAD), where higher CDK5RAP3 mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated CDK5RAP3 expression acts as an unfavorable survival marker, although some lineages such as COAD and CCRCC show a favorable association.
COAD, HNSC, and CCRCC are the cancer types where CDK5RAP3 mass-spec protein most reproducibly stratifies survival.